When researchers reported a noninvasive breakthrough in removing skin blemishes several years ago, Chris Marlett saw a chance to invest in the nano-pulse technology and make the treatment commercially available.
The CEO of investment banking firm MDB Capital Holdings convinced three competing inventors to join forces under the umbrella of a new company called Pulse Biosciences, which he eventually took public.
But the yearslong process was “crazy difficult,” Marlett said, and involved working with a slew of outside lawyers and navigating a complex patent process. He anticipates a much smoother path in his next venture—with startup money, patent protection, and legal guidance under the same roof through one of Arizona’s newest law firms: MDB Capital-owned PatentVest.